Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma

American Journal of Surgical Pathology

Volumn 34, Issue 4, 2010, Pages 510-518

  Stelow, Edward B ^a   Shaco Levy, Ruthy ^b,c   Bao, Fei ^b,d   Garcia, Joaquin ^b,e   Klimstra, David S ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Columbia University ^*  (United States)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e MAYO CLINIC   (United States)

Author keywords

Acinar cell carcinoma; Ductal adenocarcinoma; Mixed; Mucinous; Pancreas

Indexed keywords

DNA; KRAS PROTEIN, HUMAN; MUCIN; ONCOPROTEIN; RAS PROTEIN; TUMOR MARKER;

ACINAR CELL CARCINOMA; AGED; ARTICLE; CELL TRANSFORMATION; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; MUTATION; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PANCREAS ISLET CELL CARCINOMA; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; SURVIVAL RATE; UNITED STATES;

AGED; CARCINOMA, ACINAR CELL; CARCINOMA, ISLET CELL; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; COMBINED MODALITY THERAPY; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUCINS; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; NEW YORK; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VIRGINIA;

EID: 77950292941     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181cfcac7     Document Type: Article

References (36)

1. Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohis-tochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol. 2002;160:953-962.
2. Basturk O, Zamboni G, Klimstra DS, et al. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol. 2007;31:363-370.
3. Brown RW, Campagna LB, Dunn JK, et al. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol. 1997;107:12-19.
4. Cao D, Maitra A, Saavedra JA, et al. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod Pathol. 2005;18:752-761.
5. Caruso RA, Inferrera A, Tuccari G, et al. Acinar cell carcinoma of the pancreas. A histologic, immunocytochemical and ultrastructural study. Histol Histopathol. 1994;9:53-58.
6. Cingolani N, Shaco-Levy R, Farruggio A, et al. Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma. Hum Pathol. 2000;31:938-944.
7. Edlund H. Pancreas: how to get there from the gut? Curr Opin Cell Biol. 1999;11:663-668.
8. Fabre A, Sauvanet A, Flejou JF, et al. Intraductal acinar cell carcinoma of the pancreas. Virchows Arch. 2001;438:312-315.
9. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol. 1993;143:685-698.
10. Hruban RH, Pitman MB, Klimstra DS. Acinar Neoplasms. Tumors of the Pancreas. Wahington, D.C.: American Registry of Pathology; 2007:191-218.
11. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Washington, D.C.: American Registry of Pathology; 2007.
12. Itoh T, Kishi K, Tojo M, et al. Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan. Gastroenterol Jpn. 1992;27: 785-791.
13. Kitagami H, Kondo S, Hirano S, et al. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from pancreatic cancer registry of Japan pancreas society. Pancreas. 2007;35:42-46.
14. Klimstra DS, Longnecker D. Acinar cell carcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000:241-243.
15. Klimstra DS, Heffess CS, Oertel JE, et al. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol. 1992;16:815-837.
16. Klimstra DS, Rosai J, Heffess CS. Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol. 1994;18:765-778.
17. Kloppel G. Mixed exocrine-endocrine tumors of the pancreas. Semin Diagn Pathol. 2000;17:104-108.
18. Krapp A, Knofler M, Ledermann B, et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 1998;12: 3752-3763.
19. Lee MJ, Lee HS, Kim WH, et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003;16:403-410.
20. Lin YC, Lee PH, Yao YT, et al. Alpha-fetoprotein-producing pancreatic acinar cell carcinoma. J Formos Med Assoc. 2007;106: 669-672.
21. Moore PS, Orlandini S, Zamboni G, et al. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigen-esis. Br J Cancer. 2001;84:253-262.
22. Ohike N, Kosmahl M, Kloppel G. Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch. 2004;445:231-235.
23. Okada Y, Mori H, Tsutsumi A. Duct-acinar-islet cell tumor of the pancreas. Pathol Int. 1995;45:669-676.
24. Ordonez NG. Pancreatic acinar cell carcinoma. Adv Anat Pathol. 2001;8:144-159.
25. Ordonez NG, Mackay B. Acinar cell carcinoma of the pancreas. Ultrastruct Pathol. 2000;24:227-241.
26. Schaeffer BK, Terhune PG, Longnecker DS. Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc trans-genic mice do not contain c-K-ras mutations. Am J Pathol. 1994; 145:696-701.
27. Schron DS, Mendelsohn G. Pancreatic carcinoma with duct, endocrine, and acinar differentiation. A histologic, immunocyto-chemical, and ultrastructural study. Cancer. 1984;54:1766-1770.
28. Seth AK, Argani P, Campbell KA, et al. Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature. J Gastrointest Surg. 2008;12:1061-1067.
29. Shinagawa T, Tadokoro M, Maeyama S, et al. Alpha fetoprotein-producing acinar cell carcinoma of the pancreas showing multiple lines of differentiation. Virchows Arch. 1995;426:419-423.
30. Stamm BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol. 1984;15:677-683.
31. Stelow EB, Adams RB, Moskaluk CA. The prevalence of pancreatic intraepithelial neoplasia in pancreata with uncommon types of primary neoplasms. Am J Surg Pathol. 2006;30:36-41.
32. Tanaka T, Mori H, Williams GM. Atypical and neoplastic acinar cell lesions of the pancreas in an autopsy study of Japanese patients. Cancer. 1988;61:2278-2285.
33. Tanakaya K, Teramoto N, Konaga E, et al. Mixed duct-acinar-islet cell tumor of the pancreas: report of a case. Surg Today. 2001;31: 177-179.
34. Terhune PG, Heffess CS, Longnecker DS. Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog. 1994;10:110-114.
35. Terhune PG, Memoli VA, Longnecker DS. Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice. Pancreas. 1998;16:6-12.
36. Ulich T, Cheng L, Lewin KJ. Acinar-endocrine cell tumor of the pancreas. report of a pancreatic tumor containing both zymogen and neuroendocrine granules. Cancer. 1982;50:2099-2105.